Apple Downgraded by Jefferies Amid Weak iPhone Sales and AI Concerns 
Home ownership is slipping out of reach. It’s time to rethink our fear of ‘forever renting’ 
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
FDA Limits Regulation of Wearable Devices and Wellness Software, Boosting Health Tech Industry 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
Discord Confidentially Files for U.S. IPO, Signaling Major Milestone 
Intel Unveils Panther Lake AI Laptop Chips at CES 2025, Marking Major 18A Manufacturing Milestone 
SoftBank Eyes Up to $25B OpenAI Investment Amid AI Boom 
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 
Mercedes-Benz to Launch Advanced Urban Self-Driving System in the U.S., Challenging Tesla FSD 
Reliance Industries Surges on Strong Quarterly Profit, Retail Recovery 
Baidu’s AI Chip Unit Kunlunxin Prepares for Hong Kong IPO to Raise Up to $2 Billion 
TSMC Shares Hit Record High as Goldman Sachs Raises Price Target on AI Demand Outlook 
U.S. Stock Futures Rise as Trump Takes Office, Corporate Earnings Awaited 
Jollibee Plans U.S. Listing for International Business, Shares Rally 
South Korea to End Short-Selling Ban as Financial Market Uncertainty Persists 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
Tempus AI Inc (NASDAQ:TEM) shares surged over 18% to $41.62 in after-hours trading following a disclosure by former House Speaker Nancy Pelosi. Pelosi revealed in a recent filing that she had purchased 50 call options on the artificial intelligence-focused precision medicine firm. The options, priced between $50,000 and $100,000, have a $20 strike price and expire on January 16, 2026.
Pelosi’s disclosure also included call options in tech giants Alphabet Inc (NASDAQ:GOOGL), NVIDIA Corporation (NASDAQ:NVDA), and Amazon.com Inc (NASDAQ:AMZN).
The rally comes despite Tempus being down about 12% since its public listing in June 2024. The stock faced pressure last week when a major shareholder sold $33.1 million worth of shares, even after Tempus reported strong 2024 earnings. However, the company flagged a slowdown in contract research organization revenues, sparking some investor caution.
Sentiment around Tempus has turned highly bullish on trading platforms like Stocktwits, with discussions about the stock spiking after Pelosi’s disclosure. The platform reported increased interest and optimism, which contributed to the stock’s strong rally.
Tempus leverages artificial intelligence technology for precision medicine applications, and its growth potential continues to attract attention from prominent investors. This latest move by Pelosi, a well-known and closely watched figure in the investment community, has added momentum to the stock, drawing increased scrutiny from retail and institutional investors alike.
As interest in AI and precision medicine grows, Tempus is positioned as a key player, gaining visibility and market attention.
